USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer

Beiqing Pan , Yi Yang , Jian Li , Yu Wang , Chuantao Fang , Fa-Xing Yu , Yanhui Xu

Protein Cell ›› 2020, Vol. 11 ›› Issue (2) : 138 -143.

PDF (1938KB)
Protein Cell ›› 2020, Vol. 11 ›› Issue (2) : 138 -143. DOI: 10.1007/s13238-019-00674-w
LETTER
LETTER

USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer

Author information +
History +
PDF (1938KB)

Cite this article

Download citation ▾
Beiqing Pan, Yi Yang, Jian Li, Yu Wang, Chuantao Fang, Fa-Xing Yu, Yanhui Xu. USP47-mediated deubiquitination and stabilization of YAP contributes to the progression of colorectal cancer. Protein Cell, 2020, 11(2): 138-143 DOI:10.1007/s13238-019-00674-w

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

An T, Gong Y, Li X, Kong L, Ma P, Gong L, Zhu H, Yu C, Liu J, Zhou H (2017) USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth. Biochem Pharmacol 131:29–39

[2]

Barry ER, Morikawa T, Butler BL, Shrestha K, de la Rosa R, Yan KS, Fuchs CS, Magness ST, Smits R, Ogino S(2013) Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493:106–110

[3]

Cai J, Zhang N, Zheng Y, de Wilde RF, Maitra A, Pan D (2010) The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24:2383–2388

[4]

Chauhan D, Tian Z, Nicholson B, Kumar KG, Zhou B, Carrasco R, McDermott JL, Leach CA, Fulcinniti M, Kodrasov MP (2012) A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance. Cancer Cell 22:345–358

[5]

Johnson R, Halder G (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat Rev Drug Discov 13:63–79

[6]

Pan D (2010) The hippo signaling pathway in development and cancer. Dev Cell 19:491–505

[7]

Peschiaroli A, Skaar JR, Pagano M, Melino G (2010) The ubiquitinspecific protease USP47 is a novel beta-TRCP interactor regulating cell survival. Oncogene 29:1384–1393

[8]

Piccolo S, Dupont S, Cordenonsi M (2014) The biology of YAP/TAZ: hippo signaling and beyond. Physiol Rev 94:1287–1312

[9]

Popovic D, Vucic D, Dikic I (2014) Ubiquitination in disease pathogenesis and treatment. Nat Med 20:1242–1253

[10]

Steinhardt AA, Gayyed MF, Klein AP, Dong J, Maitra A, Pan D, Montgomery EA, Anders RA (2008) Expression of Yes-associated protein in common solid tumors. Hum Pathol 39:1582–1589

[11]

Wang Y, Yu A, Yu FX (2017) The Hippo pathway in tissue homeostasis and regeneration. Protein Cell 8:349–359

[12]

Yao F, Zhou Z, Kim J, Hang Q, Xiao Z, Ton BN, Chang L, Liu N, Zeng L, Wang W(2018) SKP2- and OTUD1-regulated nonb proteolytic ubiquitination of YAP promotes YAP nuclear localization and activity. Nat Commun 9:2269

[13]

Yu FX, Meng Z, Plouffe SW, Guan KL (2015) Hippo pathway regulation of gastrointestinal tissues. Annu Rev Physiol 77:201–227

[14]

Zhang Z, Du J, Wang S, Shao L, Jin K, Li F, Wei B, Ding W, Fu P, van Dam H (2019) OTUB2 promotes cancer metastasis via Hippo-independent activation of YAP and TAZ. Mol Cell 73:7–21.e27

[15]

Zhao B, Li L, Tumaneng K, Wang CY, Guan KL (2010) A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24:72–85

RIGHTS & PERMISSIONS

The Author(s) 2019

AI Summary AI Mindmap
PDF (1938KB)

Supplementary files

PAC-0139-19006-YFX_suppl_1

550

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/